Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 1,3,4-Thiadiazole Derivatives Targeting Both Aldose Reductase and α‑Glucosidase for Diabetes Mellitus

Ähnliche Einträge

• Identification of Indazole-Based Thiadiazole-Bearing Thiazolidinone Hybrid Derivatives: Theoretical and Computational Approaches to Develop Promising Anti-Alzheimer’s Candidates
  von: Yousaf Khan, et al.
  Veröffentlicht: (2023-11-01)
• Neuroprotective Effects of Blueberries through Inhibition on Cholinesterase, Tyrosinase, Cyclooxygenase-2, and Amyloidogenesis
  von: Pari Samani, et al.
  Veröffentlicht: (2023-01-01)
• The Potential Role of Cholinesterase in Diabetes Mellitus and Metabolic Syndrome
  von: Muwafaq Zaya, et al.
  Veröffentlicht: (2026-03-01)
• Synthesis, Docking and Acetylcholinesterase Inhibitory Evaluation of 1,3,4-Thiadiazole Derivatives as Potential Anti-Alzheimer Agents
  von: Ahmad Mohammadi-Farani, et al.
  Veröffentlicht: (2024-07-01)
• HRMS-based profiling of metabolites, metal ions content and in-vitro cholinesterase inhibitory activities of Sonchus wightianus DC plant parts
  von: Abhimat Subedi, et al.
  Veröffentlicht: (2026-01-01)